EVENTIDE ASSET MANAGEMENT, LLC
Q1 2024 13F-HR Holdings
Net value change ($000)
+250,445
(4.1%)
New positions
24
Sold out positions
19
Turnover %
9.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Shockwave Medical, Inc. | 68,766 | 71.3% |
| TTD | 58,176 | 78.4% |
| TT | 45,768 | 23.5% |
| CPRT | 41,309 | NEW |
| ROL | 40,793 | 190.5% |
| GTLB | 40,573 | NEW |
| CELC | 30,024 | NEW |
| MDB | 29,528 | 136.3% |
| DDOG | 28,853 | 29.8% |
| MSCI | 27,976 | 170.4% |
Top Reduces (Value $000, Stocks/ETFs)
| XMTR | -118,580 | -58.0% |
| PANW | -62,240 | -50.4% |
| Karuna Therapeutics, Inc. | -60,137 | -100.0% |
| LNG | -51,422 | -100.0% |
| APTV | -50,507 | -71.7% |
| CRWD | -47,428 | -37.2% |
| DLO | -46,489 | -48.5% |
| BILL | -42,681 | -100.0% |
| CYTK | -28,602 | -61.6% |
| MARINUS PHARMACEUTICALS, INC. | -28,028 | -56.9% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,240
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|